Completed
Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma
NCT00354913
- Conditions
- Astrocytoma, Brain Diseases, Brain Neoplasms, +18 more
- Locations
-
- Duke Cancer Institute Durham, North Carolina, United States